TREATMENT OF EXPERIMENTAL LEGIONNAIRES' DISEASE BY AEROSOL ADMINISTRATION OF RIFAMPICIN, CIPROFLOXACIN, AND ERYTHROMYCIN
- 1 March 1986
- journal article
- letter
- Published by Elsevier in The Lancet
- Vol. 327 (8479) , 502-503
- https://doi.org/10.1016/s0140-6736(86)92960-0
Abstract
No abstract availableThis publication has 9 references indexed in Scilit:
- NEBULISED RIBAVIRIN FOR ADENOVIRUS PNEUMONIAThe Lancet, 1985
- INHALED CORTICOSTEROIDS FOR RESPIRATORY DISTRESS?The Lancet, 1985
- Evaluation of jet nebulisers for use with gentamicin solution.Thorax, 1985
- The effect of antibiotics on the growth of Legionella pneumophila in guinea-pig alveolar phagocytes infected in vivo by an aerosolJournal of Infection, 1985
- Studies on ciprofloxacin therapy of experimental Legionnaires' diseaseJournal of Infection, 1985
- Therapeutic aerosols 2--Drugs available by the inhaled route.Thorax, 1984
- Antibiotic therapy of experimental airborne Legionnaires' diseaseJournal of Infection, 1983
- EXPERIMENTAL TRANSMISSION OF LEGIONNAIRES' DISEASE BY EXPOSURE TO AEROSOLS OF LEGIONELLA PNEUMOPHILAThe Lancet, 1981
- Improved semiselective medium for isolation of Legionella pneumophila from contaminated clinical and environmental specimensJournal of Clinical Microbiology, 1981